{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:54:16Z","timestamp":1757314456431,"version":"3.37.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.gastha.2024.08.023","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:37:44Z","timestamp":1725471464000},"page":"100545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-6357","authenticated-orcid":false,"given":"Tessa","family":"Dieckman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Schreurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciska","family":"Lindelauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline R.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Pigeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van Unen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-5715","authenticated-orcid":false,"given":"Frits","family":"Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gastha.2024.08.023_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gastha.2024.08.023_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gutjnl-2012-302265","article-title":"Identification of a\u00a0potential physiological precursor of aberrant cells in refractory coeliac disease type II","volume":"62","author":"Schmitz","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gastha.2024.08.023_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-Dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.gastha.2024.08.023_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.gastha.2024.08.023_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","article-title":"Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II","volume":"45","author":"Soderquist","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","article-title":"Origin and immunophenotype of aberrant IEL in RCDII patients","volume":"50","author":"Tack","year":"2012","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.gastha.2024.08.023_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcmgh.2022.03.005","article-title":"Single-cell analysis of Refractory Celiac Disease demonstrates inter- and intra-patient aberrant cell heterogeneity","volume":"14","author":"Dieckman","year":"2022","journal-title":"Cell Molecular Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1593\/tlo.08178","article-title":"Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments","volume":"1","author":"Pienta","year":"2008","journal-title":"Translational oncology"},{"issue":"5256","key":"10.1016\/j.gastha.2024.08.023_bib11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.gastha.2024.08.023_bib12","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.13895","article-title":"PD-1 and its ligands are important immune checkpoints in cancer","volume":"8","author":"Dong","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gastha.2024.08.023_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/cgf.12893","article-title":"Cytosplore: interactive immune cell phenotyping for Large single-cell datasets","volume":"35","author":"H\u00f6llt","year":"2016","journal-title":"Comput Graph Forum"},{"issue":"1","key":"10.1016\/j.gastha.2024.08.023_bib14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/s41467-017-01689-9","article-title":"Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types","volume":"8","author":"van Unen","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gastha.2024.08.023_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"43","key":"10.1016\/j.gastha.2024.08.023_bib16","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.gastha.2024.08.023_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Systems"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.gastha.2024.08.023_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nri1867","article-title":"The GITR\u2013GITRL interaction: co-stimulation or contrasuppression of regulatory activity?","volume":"6","author":"Shevach","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.gastha.2024.08.023_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","article-title":"Not-so-opposite ends of the spectrum: CD8(+) T cell dysfunction across chronic infection, cancer and autoimmunity","volume":"22","author":"Collier","year":"2021","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.gastha.2024.08.023_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ijc.33859","article-title":"NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division","volume":"150","author":"Borst","year":"2022","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.gastha.2024.08.023_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.gastha.2024.08.023_bib23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/cancers11101611","article-title":"Screening a broad range of solid and haematological tumour types for CD70 expression using a uniform IHC methodology as potential patient stratification method","volume":"11","author":"Flieswasser","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.gastha.2024.08.023_bib24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/imt.15.32","article-title":"Targeting the T-cell co-stimulatory CD27\/CD70 pathway in cancer immunotherapy: rationale and potential","volume":"7","author":"van de Ven","year":"2015","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.gastha.2024.08.023_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2141.1999.01573.x","article-title":"Aberrant expression and reverse signalling of CD70 on malignant B cells","volume":"106","author":"Lens","year":"1999","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.gastha.2024.08.023_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068432","article-title":"Changes in natural Foxp3+Treg but not mucosally-imprinted CD62LnegCD38+Foxp3+Treg in the circulation of celiac disease patients","volume":"8","author":"van Leeuwen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gastha.2024.08.023_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"van Hall","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.gastha.2024.08.023_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.592569","article-title":"Helpless priming Sends CD8(+) T cells on the road to exhaustion","volume":"11","author":"Busselaar","year":"2020","journal-title":"Front Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.gastha.2024.08.023_bib29","article-title":"New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)","volume":"4","author":"Starzer","year":"2020","journal-title":"ESMO open"},{"issue":"1","key":"10.1016\/j.gastha.2024.08.023_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-021-02215-y","article-title":"The CD70-CD27 axis in oncology: the new kids on the block","volume":"41","author":"Flieswasser","year":"2022","journal-title":"J\u00a0Exp Clin Cancer Res"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T03:14:59Z","timestamp":1737429299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572324001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2772572324001390"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2024.08.023","relation":{},"ISSN":["2772-5723"],"issn-type":[{"type":"print","value":"2772-5723"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2024.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100545"}}